INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,792,000 | -82.0% | 236,547 | -73.1% | 0.88% | -74.4% |
| Q4 2019 | $21,015,000 | +30.2% | 880,016 | -3.8% | 3.46% | +1.4% |
| Q3 2019 | $16,141,000 | -34.0% | 915,016 | -4.2% | 3.41% | -75.2% |
| Q2 2019 | $24,460,000 | -8.5% | 955,462 | +3.9% | 13.75% | +14.0% |
| Q1 2019 | $26,728,000 | +110.5% | 919,436 | -5.0% | 12.07% | +79.4% |
| Q4 2018 | $12,695,000 | -35.1% | 967,636 | 0.0% | 6.73% | -7.1% |
| Q3 2018 | $19,566,000 | -14.5% | 967,636 | 0.0% | 7.24% | -10.2% |
| Q2 2018 | $22,885,000 | +5.0% | 967,636 | 0.0% | 8.06% | +11.2% |
| Q1 2018 | $21,791,000 | +34.8% | 967,636 | +86.6% | 7.25% | +28.3% |
| Q4 2017 | $16,171,000 | +72.7% | 518,645 | +72.9% | 5.65% | +48.9% |
| Q3 2017 | $9,363,000 | – | 300,000 | – | 3.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |